Search Results 551-560 of 17341 for alopecia
excluding alopecia. - Women of childbearing potential (WCBP) must have a negative urine or serum pregnancy test within 28 days of starting the study drug ...
Toxicity from a previous anti-tumor treatment that does not return to Grade 0 or 1 (except for alopecia). Known human immunodeficiency virus (HIV) ...
Bone cancer most commonly affects the long bones in the arms and legs. Some types happen mostly in children, while others affect mostly adults.
DEAR MAYO CLINIC: I have high blood pressure and was just diagnosed as having chronic kidney disease. I am disheartened by this news, but I[...] ...
Patients with vitiligo or alopecia Patients with hypothyroidism (eg, following Hashimoto syndrome) stable on hormone replacement Any chronic skin ...
Learn about this rare condition that causes tumors to grow and too many hormones to be made.
... alopecia, vitiligo). Subjects with Grade 2 toxicities that are deemed stable or irreversible (e.g., peripheral neuropathy) can be enrolled. For ...
Platelet-rich plasma injections are also a new treatment option for alopecia — hair loss and baldness. Research at Mayo Clinic in Florida discovered that ...
World Lymphoma Day is September 15 ROCHESTER, Minnesota — For many doctors and researchers, immunotherapy that uses someone's own immune system to target ...
Resolution of all toxicities from prior therapy to ≤ Grade 1 (or patient baseline) within 1 week prior to the first dose of study drug (excluding alopecia ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.